SEC Form 4 · accession 0001493152-16-010353
Ernexa Therapeutics Inc. · ERNA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ram Krishnan
Officer — CEO · Director
Period of report
May 26, 2016
Accepted (ET)
May 26, 2016 · 8:22 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000748592
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 26, 2016 | P | 44,700 | $0.16 | A | 139,700 | D | |
| Common Stock | May 26, 2016 | P | 3,200 | $0.1599 | A | 142,900 | D | |
| Common Stock | May 26, 2016 | P | 700 | $0.1588 | A | 143,600 | D | |
| Common Stock | May 26, 2016 | P | 700 | $0.1598 | A | 144,300 | D | |
| Common Stock | May 26, 2016 | P | 700 | $0.1597 | A | 145,000 | D |
Table II — derivative securities
No Table II lines on this filing.